Extracellular vesicles (EVs) are nanoparticles released from various cell types that have
emerged as powerful new therapeutic option for a variety of diseases. EVs are involved in …

Hepatic ischemia-reperfusion injury (HIRI) is the major complication of liver surgery and liver
transplantation, that may increase the postoperative morbidity, mortality, tumor progression …

Hepatic ischemia-reperfusion injury (HIRI) is the cause of postoperative hepatic dysfunction
and failure, and even death. As an important biological effector molecule, hydrogen sulfide …

Transplantations represent the principal therapeutic interventions for terminal organ failure,
a procedure that has salvaged myriad lives annually. Ischemia/reperfusion injury (IRI) is …

Acute liver failure caused by hepatic ischemia reperfusion injury (HIRI) poses a severe
threat to life, emphasizing the urgent need for precise and timely early diagnosis. Viscosity, a …

This protocol presents an optimized erythrocytes-free NEVLP system using mouse livers. Ex
vivo preservation of mouse livers was achieved by employing modified cannulas and …

Background Hepatic ischemia–reperfusion (IR) injury is a major complication of liver
transplantation and gravely affects patient prognosis. Icaritin (ICT), the primary plasma …

Liver ischemia-reperfusion injury (LIRI) can occur during liver resection, liver transplantation,
shock, and other hemorrhagic conditions, resulting in profound local and systemic effects via …

The progression of liver diseases, from viral hepatitis and fatty liver disease to cirrhosis and
hepatocellular carcinoma (HCC), is the most representative series of pathological events in …

Despite being an effective chemotherapeutic agent, the clinical use of doxorubicin (DOX) is
limited by several organ toxicities including hepatic injury. Pentoxifylline (PTX) is a …